Literature DB >> 31548800

Psychedelics for psychological and existential distress in palliative and cancer care.

D Rosenbaum1, A B Boyle2, A M Rosenblum3, S Ziai1,2,3, M R Chasen1,2,3, MPhil Pall Med3.   

Abstract

Entities:  

Year:  2019        PMID： 31548800      PMCID： PMC6726261          DOI： 10.3747/co.26.5009

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  16 in total

Review 1.  Psychedelic medicine: a re-emerging therapeutic paradigm.

Authors:  Kenneth W Tupper; Evan Wood; Richard Yensen; Matthew W Johnson
Journal:  CMAJ       Date:  2015-09-08       Impact factor: 8.262

2.  Effects of existential interventions on spiritual, psychological, and physical well-being in adult patients with cancer: Systematic review and meta-analysis of randomized controlled trials.

Authors:  Natalie Bauereiß; Stefanie Obermaier; Selçuk Erol Özünal; Harald Baumeister
Journal:  Psychooncology       Date:  2018-08-02       Impact factor: 3.894

Review 3.  Human hallucinogen research: guidelines for safety.

Authors:  Mw Johnson; Wa Richards; Rr Griffiths
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

Review 4.  Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology.

Authors:  Ido Hartogsohn
Journal:  J Psychopharmacol       Date:  2016-11-16       Impact factor: 4.153

5.  Demoralization and death anxiety in advanced cancer.

Authors:  Ekaterina An; Christopher Lo; Sarah Hales; Camilla Zimmermann; Gary Rodin
Journal:  Psychooncology       Date:  2018-08-20       Impact factor: 3.894

6.  Depression and anxiety disorders in palliative cancer care.

Authors:  Keith G Wilson; Harvey Max Chochinov; Merika Graham Skirko; Pierre Allard; Srini Chary; Pierre R Gagnon; Karen Macmillan; Marina De Luca; Fiona O'Shea; David Kuhl; Robin L Fainsinger; Jennifer J Clinch
Journal:  J Pain Symptom Manage       Date:  2007-02       Impact factor: 3.612

Review 7.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 8.  Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress.

Authors:  Stephen Ross
Journal:  Int Rev Psychiatry       Date:  2018-08-13

9.  Mental disorders and the desire for death in patients receiving palliative care for cancer.

Authors:  Keith G Wilson; Tracy L Dalgleish; Harvey Max Chochinov; Srini Chary; Pierre R Gagnon; Karen Macmillan; Marina De Luca; Fiona O'Shea; David Kuhl; Robin L Fainsinger
Journal:  BMJ Support Palliat Care       Date:  2014-03-04       Impact factor: 3.568

10.  Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.

Authors:  Roland R Griffiths; Matthew W Johnson; Michael A Carducci; Annie Umbricht; William A Richards; Brian D Richards; Mary P Cosimano; Margaret A Klinedinst
Journal:  J Psychopharmacol       Date:  2016-12       Impact factor: 4.153
View more
  2 in total

Review 1.  Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Authors:  Nina Schimmel; Joost J Breeksema; Sanne Y Smith-Apeldoorn; Jolien Veraart; Wim van den Brink; Robert A Schoevers
Journal:  Psychopharmacology (Berl)       Date:  2021-11-23       Impact factor: 4.530

2.  Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.

Authors:  Halsey Niles; Colleen Fogg; Ben Kelmendi; Mark Lazenby
Journal:  BMC Palliat Care       Date:  2021-12-20       Impact factor: 3.234
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.